INGR vs UTI
Ingredion vs Universal Technical Institute, Inc. — AI-powered side-by-side comparison
VS
UTI
Universal Technical Institute, Inc.
53
Watch
| Metric | INGR | UTI |
| AI Score |
62
|
53
|
| Price |
$104.70
|
$25.56
|
| P/E Ratio |
11.25×
|
40.60×
|
| ROE |
16.8%
|
19.2%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
23.7%
|
61.5%
|
| Debt / Equity |
0.39×
|
1.04×
|
| Dividend Yield |
3.1%
|
0.0%
|
| RSI (14) |
57.8
|
20.6
|
| Beta |
0.606
|
1.236
|
| Expected Upside |
+1.6%
|
—
|
AI Committee View
Current Innellis committee reasoning for INGR versus UTI.
INGR leads by 9 points.
INGR scores 62/100 (Buy) versus UTI at 53/100 (Watch).
INGR Committee View
60% agreement
5 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is revenue declining -1.4% yoy -- this is not a growth story right now. The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 11.1 is inexpensive for the broad market — Value
- Dividend yield of 3.2% pays you to wait — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- Revenue declining -1.4% YoY -- this is not a growth story right now — Growth
- EPS declining -10.3% YoY despite any revenue growth — Growth
UTI Committee View
67% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Technical Analyst remains cautious — rsi at 21 is in oversold territory (could mean either capitulation or a bounce setup). This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Low leverage (debt-to-equity 0.27) -- balance sheet can absorb a shock — Risk
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 37.4 is moderate-to-rich — Value
- Price-to-book of 5.4x prices in significant intangible value — Value
- EPS declining -25.9% YoY despite any revenue growth — Growth